Healthcare Contract Manufacturing Market Research Report: Information by Type (Sterile and Non-Sterile), Service Type (Pharmaceutical Contract Manufacturing and Medical Device Contract Manufacturing), Industry (Pharmaceutical Industry, Medical Device Industry and Biopharmaceutical Industry) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027
ID: MRFR/HS/4182-CR | August 2019 | Region: Global | 90 pages
Healthcare Contract Manufacturing Market Scenario:
The Healthcare Contract Manufacturing Market is expected to register 9.86% CAGR and is projected to reach USD 250.9 Billion by 2023. Contract manufacturing refers to a manufacturer who signs a contract with another company to make and provide individual components or products over a mutually agreed period. The healthcare contract manufacturing organization serves other companies in the medical devices and pharmaceutical industries to provide comprehensive services from drug development to drug manufacturing.
Some of the major drivers for the growth of healthcare contract manufacturing market across the globe are patent expiration of major drugs and medical devices, competition and economics of production and trade to favor contract manufacturing organization (CMO), mutual benefits to contract manufacturer and client, and lean manufacturing and agility. On the flip side, supply chain complexity and issues of control of third parties and standardization and interoperability issues are anticipated to hinder the market growth over the forecast period.
Market Dynamics
There is a major patent cliff occurring in the healthcare market worldwide, specifically, in the pharmaceutical industry. The patent cliff will result in cheaper generic versions in the market, which will increase the demand for CMOs. The increased demand is expected to benefit the healthcare contract manufacturing industry. Due to patent expirations, it is assumed that drug sales are anticipated to face a loss of around USD 75 billion between 2016 and 2023. Roughly the drug sales of USD 60 billion is expected to be threatened by generics. The off-patent drugs in 2016 were adalimumab, ledipasvir/sofosbuvir, rituximab, bevacizumab, and trastuzumab. Thus, patent protection expiration of major prescription drugs and the growing demand for generic drugs are likely to boost the growth of CMOs globally.
Global Healthcare Contract Manufacturing Market Size, by Industry, 2016 (%) 
Source: MRFR Analysis
Segmentation
The healthcare contract manufacturing market has been segmented into type, service type, and industry.
Based on type, the global market has been divided into sterile and non-sterile.
Based on service type, the global market has been segmented into pharmaceutical industry, medical device industry, and biopharmaceutical industry.
Based on industry, the global market has been classified as pharmaceutical industry, medical device industry, and biopharmaceutical industry. The medical devices segment dominated the market in 2016 by holding 43.7% revenue share of the market owing to the rampant growth of the global medical device industry. For instance, according to the Department of Pharmaceuticals, Government of India (GOI), the global medical device market was at USD 228 billion in 2015, which is projected to reach USD 332 billion by 2020.
Regional Analysis
Based on region, the healthcare contract manufacturing market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
In the last couple of decades, contract manufacturers in the Americas have significantly upgraded their factories and manufacturing capabilities with advanced manufacturing units and cost-efficient models. The Americas currently dominates the healthcare contract manufacturing market owing to the presence of major pharmaceutical drug manufacturers, flourishing pharmaceutical industry, and leading medical device companies in the US and Canada.
The contract manufacturing scenario in the market in Europe differs from the Americas in terms of its business model. The major client base of the contract manufacturers in Europe are generic drug companies, whereas, in the Americas, the core client base are branded drug manufacturers. Major factors influencing the growth of the European market include the presence of major manufacturers, boost in the biopharmaceutical sector, government support for research and development, increasing disposable income, and availability of technologically advanced products.
Asia-Pacific is expected to register a comparatively higher CAGR over the forecast period. Countries such as China and India continue to draw a significant amount of outsourcing work from developed countries owing to factors such as large-scale manufacturing capacity, low labor cost, low raw material cost, and low manufacturing cost. Apart from that, some of the major factors influencing the growth of the market include, increasing healthcare expenditure, increasing R&D funding by manufacturers, and moreover multinational medical device manufacturing companies seeking opportunities in the region and expanding their presence in the region. The changing medical device regulatory landscape has been a concern for the healthcare contract manufacturing market in the region. For instance, according to the Organisation for Economic Cooperation and Development (OECD), the average OECD current health spending per capita in 2015 was around twenty times that of the low-income countries and territories in Asia-Pacific (3,800 versus USD PPP 193).
The Middle East & Africa contributes least in the healthcare contract manufacturing market. However, the scenario is changing as the Gulf Cooperation Council (GCC) pharmaceutical and biotechnology companies are undergoing a phase of self-expansion, gearing up to develop a competition for established players in the contract manufacturing market. The increasing development in the Middle Eastern countries for the medical sector, increasing R&D spending, and expansion of multinational companies in the region are also influencing the growth of the market.
Key Players
The prominent players in the healthcare contract manufacturing market are Boehringer Ingelheim, AbbVie, Grifols International, S.A, Lonza AG, Catalant, Aesica Pharmaceuticals, Benchmark Electronics, Evonik Industries, Flex Ltd, Forefront Medical Technologies, Teva Pharmaceutical Industries, Hamilton Company, Sanmina Corporation, Patheon, Mylan, and Vetter Pharma International.
Key strategies followed by the participants of the healthcare contract manufacturing market were innovation, product development, acquisition, and expansion.
Key Updates
- In April 2019, West Pharmaceutical Services, Inc. (US), a global leader in innovative solutions for injectable drug administration, has expanded its presence in Asia-Pacific with a new sales office in South Korea.
- In March 2019, Nemera and Novo Nordisk A/S collaborated to build a new manufacturing site in France to manufacture injectable devices. This collaboration supported market growth in the country.
- In August 2018, Catalent, Inc. acquired Juniper Pharmaceuticals, Inc., a UK-based company, which provides high-end fee-for-service pharmaceutical development and clinical trials manufacturing. This acquisition has expanded and strengthened Catalent’s offerings in formulation development, bioavailability solutions and clinical-scale oral dose manufacturing, and complemented its integrated worldwide clinical and commercial supply network.
Market Segmentation
Healthcare Contract Manufacturing Market, by Type
- Sterile
- Non-Sterile
Healthcare Contract Manufacturing Market, by Service Type
- Pharmaceutical Contract Manufacturing
- Medical Device Contract Manufacturing
Healthcare Contract Manufacturing Market, by Industry
- Pharmaceutical Industry
- Medical Device Industry
- Biopharmaceutical Industry
Healthcare Contract Manufacturing Market, by Region
- Americas
- North America
- US
- Canada
- Latin America
- North America
- Europe
- Western Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- Oman
- Kuwait
- Qatar
- Rest of Middle East & Africa
Available Additional Customizations
- Additional Companies
- Jabil Inc.
- Nipro Corporation
- Flex, Ltd.
- West Pharmaceutical Services, Inc.
- Phillips-Medisize Corporation
- Mega Trends in the Market
- Pricing Analysis
Intended Audience
- Pharmaceutical and biotechnology companies
- Pharmaceutical and biotechnology manufacturers and distributors
- Medical device manufacturers and distributors
- Research and development (R&D) companies
- Market research and consulting service providers
- Potential investors
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size |
|
| CAGR | 9.86% (2017-2023) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Industry |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Boehringer Ingelheim, AbbVie, Grifols International, S.A, Lonza AG, Catalant, Aesica Pharmaceuticals, Benchmark Electronics, Evonik Industries, Flex Ltd, Forefront Medical Technologies, Teva Pharmaceutical Industries, Hamilton Company, Sanmina Corporation, Patheon, Mylan, and Vetter Pharma International. |
| Key Market Opportunities | New product launches and R&D Amongst major key Players |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Healthcare contract manufacturing market projected to grow at approximately 9.86% CAGR during the assessment period (2017-2023).
The valuation of the healthcare contract manufacturing market is estimated to increase to USD 250.9 BN by the end of 2023.
Major cliffing in the healthcare and pharmaceutical industry worldwide and government support, are major tailwinds pushing the growth of the healthcare contract manufacturing market.
North America holds the largest share in thehealthcare contract manufacturing market, followed by Europe and the Asia Pacific, respectively.
AbbVie, Boehringer Ingelheim, Vetter Pharma International, Grifols International, S.A, Mylan, Catalant, Lonza AG, Patheon, Sanmina Corporation, Aesica Pharmaceuticals, Hamilton Company, Evonik Industries, Benchmark Electronics, Flex Ltd, Teva Pharmaceutical Industries, and Forefront Medical Technologies, are some of the top players operating in the healthcare contract manufacturing market.
1 Report Prologue
2 Market Introduction
2.1 Definition 19
2.2 Scope of the Study 19
2.3 List of Assumptions 19
2.4 Market Structure 20
3 Research Methodology
3.1 Research Process 22
3.2 Primary Research 23
3.3 Secondary Research 24
3.4 Market Size Estimation 25
3.5 Forecast Model 25
4 Market Dynamics
4.1 Introduction 27
4.2 Drivers 28
4.2.1 Patent Protection Expiration of Major Drugs and Medical Devices Will Boost the Market Growth 28
4.2.2 Competition and Economics of Production and Trade to Favor CMO 28
4.2.3 Mutual Benefits to Both Contract Manufacturer and Client are Likely to Have a Positive Impact on Healthcare Contract Manufacturing 28
4.2.4 Lean Manufacturing and Agility 29
4.3 Restraints 30
4.3.1 Supply Chain Complexity and Issues of Control of 3rd Parties May Hamper the Market 30
4.3.2 Standardization and Interoperability Issues 30
4.3.3 Growing Cost of Noncompliance and Counterfeited Medicines May Hamper the Market Growth 30
4.4 Opportunities 31
4.4.1 Research & Development 31
4.4.2 Personalization & Customization 31
4.5 Challenges 32
4.5.1 Loss of Research and Innovation Ability 32
4.5.2 Growth in Exposure to Natural and Human-Made Threats 32
5 Market Factor Analysis
5.1 Value/Supply Chain Analysis 34
5.1.1 Raw Material 34
5.1.2 Supplier 34
5.1.3 Manufacturer 35
5.1.4 Distributor 36
5.1.5 Customer 36
5.1.6 Consumer 36
5.2 Porter’s Five Force Analysis 37
5.2.1 Threat from a New Entrant 38
5.2.2 Bargaining Power of Buyer 38
5.2.3 Bargaining Power of Supplier 39
5.2.4 Threat from Substitute 39
5.2.5 Rivalry 39
5.3 Investment Opportunity Analysis 40
5.3.1 Market Size (Current & Future), Growth Rate & Profitability 40
5.3.2 Investment Risks 40
5.3.3 Market outlook 40
6 Global Healthcare Contract Manufacturing Market, by Type
6.1 Overview 42
6.1.1 Sterile 43
6.1.2 Non-Sterile 43
7 Global Healthcare Contract Manufacturing Market, by Service Type
7.1 Overview 45
7.1.1 Pharmaceutical Contract Manufacturing 46
7.1.2 Medical Device Contract Manufacturing 47
8 Global Healthcare Contract Manufacturing Market, by Industry
8.1 Overview 50
8.1.1 Pharmaceutical Industry 51
8.1.2 Medical Device Industry 52
8.1.3 Biopharmaceutical Industry 52
9 Global Healthcare Contract Manufacturing Market, by Region
9.1 Introduction 54
9.2 Americas 56
9.2.1 North America 59
9.2.1.1 US. 62
9.2.1.2 Canada 64
9.2.2 South America 67
9.3 Europe 70
9.3.1 Western Europe 73
9.3.1.1 Germany 76
9.3.1.2 France 78
9.3.1.3 US 81
9.3.1.4 Italy 83
9.3.1.5 Spain 85
9.3.1.6 Rest of Western Europe 88
9.3.2 Eastern Europe 90
9.4 Asia-Pacific 93
9.4.1 Japan 96
9.4.2 China 99
9.4.3 India 101
9.4.4 Australia 104
9.4.5 South Korea 106
9.4.6 Rest of Asia-Pacific 108
9.5 Middle East & Africa 111
9.5.1 United Arab Emirates 114
9.5.2 Saudi Arabia 117
9.5.3 Oman 119
9.5.4 Kuwait 122
9.5.5 Qatar 124
9.5.6 Rest of Middle East & Africa 126
10 Competitive Landscape
10.1 Introduction 130
10.1.1 Company Share Analysis 130
11 Company Profiles
11.1 Catalant 133
11.1.1 Company Overview 133
11.1.2 Financial Overview 133
11.1.3 Products/Services Offered 134
11.1.4 Key Developments 134
11.1.5 SWOT Analysis 134
11.1.6 Key Strategies 134
11.2 Boehringer Ingelheim 135
11.2.1 Company Overview 135
11.2.2 Financial Overview 135
11.2.3 Products/Services Offered 136
11.2.4 Key Developments 136
11.2.5 SWOT Analysis 137
11.2.6 Key Strategies 137
11.3 Lonza AG 138
11.3.1 Company Overview 138
11.3.2 Financial Overview 138
11.3.3 Products/Services Offered 139
11.3.4 Key Developments 139
11.3.5 SWOT Analysis 139
11.3.6 Key Strategies 139
11.4 Grifols International, S.A 140
11.4.1 Company Overview 140
11.4.2 Financial Overview 140
11.4.3 Products/Services Offered 141
11.4.4 Key Developments 141
11.4.5 SWOT Analysis 141
11.4.6 Key Strategies 141
11.5 AbbVie Inc 142
11.5.1 Company Overview 142
11.5.2 Financial Overview 142
11.5.3 Products/Services Offered 143
11.5.4 Key Developments 143
11.5.5 SWOT Analysis 143
11.5.6 Key Strategies 143
11.6 Patheon Inc 144
11.6.1 Company Overview 144
11.6.2 Financial Overview 144
11.6.3 Products/Services Offered 145
11.6.4 Key Developments 145
11.6.5 SWOT Analysis 145
11.6.6 Key Strategies 145
11.7 Vetter Pharma 146
11.7.1 Company Overview 146
11.7.2 Financial Overview 146
11.7.3 Products/Services Offered 146
11.7.4 Key Developments 146
11.7.5 SWOT Analysis 147
11.7.6 Key Strategies 147
11.8 Pharmaceutical Product Development 148
11.8.1 Company Overview 148
11.8.2 Financial Overview 148
11.8.3 Products/Services Offered 148
11.8.4 Key Developments 149
11.8.5 SWOT Analysis 149
11.8.6 Key Strategies 149
11.9 Teva Pharmaceutical Industries Limited 150
11.9.1 Company Overview 150
11.9.2 Financial Overview 150
11.9.3 Products/Services Offered 151
11.9.4 Key Developments 151
11.9.5 SWOT Analysis 151
11.9.6 Key Strategies 151
11.10 Aesica Pharmaceuticals Ltd 152
11.10.1 Company Overview 152
11.10.2 Financial Overview 152
11.10.3 Products/Services Offered 152
11.10.4 Key Developments 152
11.10.5 SWOT Analysis 153
11.10.6 Key Strategies 153
11.11 Pfizer Inc. 154
11.11.1 Company Overview 154
11.11.2 Financial Overview 154
11.11.3 Products/Services Offered 155
11.11.4 Key Developments 155
11.11.5 SWOT Analysis 155
11.11.6 Key Strategies 155
11.12 Baxter Biopharma Solutions 156
11.12.1 Company Overview 156
11.12.2 Financial Overview 156
11.12.3 Products/Services Offered 157
11.12.4 Key Developments 157
11.12.5 SWOT Analysis 158
11.12.6 Key Strategies 158
11.13 Jubilant Life Sciences Limited 159
11.13.1 Company Overview 159
11.13.2 Financial Overview 159
11.13.3 Products/Services Offered 160
11.13.4 Key Developments 160
11.13.5 SWOT Analysis 160
11.13.6 Key Strategies 160
11.14 Nipro Corporation 161
11.14.1 Company Overview 161
11.14.2 Financial Overview 161
11.14.3 Products/Services Offered 162
11.14.4 Key Developments 162
11.14.5 SWOT Analysis 162
11.14.6 Key Strategies 162
11.15 NextPharma Technologies 163
11.15.1 Company Overview 163
11.15.2 Financial Overview 163
11.15.3 Products/Services Offered 164
11.15.4 Key Developments 164
11.15.5 SWOT Analysis 164
11.15.6 Key Strategies 164
12 Conclusion
12.1 Key Findings 166
12.1.1 Key Companies to Watch 166
12.1.2 Prediction of the Healthcare Contract Manufacturing Industry 166
13 Appendix
13.1 Discussion Blue Print 168
14 List of Tables
TABLE 1 LIST OF ASSUMPTIONS 19
TABLE 2 PRIMARY INTERVIEWS 22
TABLE 3 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 43
TABLE 4 GLOBAL STERILE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020-2027 (USD BILLION) 43
TABLE 5 GLOBAL NON-STERILE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020-2027 (USD BILLION) 43
TABLE 6 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 46
TABLE 7 GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY REGION, 2020-2027 (USD BILLION) 46
TABLE 8 GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 46
TABLE 9 GLOBAL FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 47
TABLE 10 GLOBAL MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY REGION, 2020-2027 (USD BILLION) 47
TABLE 11 GLOBAL MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 47
TABLE 12 GLOBAL DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 48
TABLE 13 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 51
TABLE 14 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET FOR PHARMACEUTICAL INDUSTRY BY REGION, 2020-2027 (USD BILLION) 51
TABLE 15 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET FOR MEDICAL DEVICE INDUSTRY BY REGION, 2020-2027 (USD BILLION) 52
TABLE 16 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET FOR BIOPHARMACEUTICAL INDUSTRY BY REGION, 2020-2027 (USD BILLION) 52
TABLE 17 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020-2027 (USD BILLION) 55
TABLE 18 AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020-2027 (USD BILLION) 56
TABLE 19 AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 57
TABLE 20 AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 57
TABLE 21 AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 57
TABLE 22 AMERICAS FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 58
TABLE 23 AMERICAS MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 58
TABLE 24 AMERICAS DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 58
TABLE 25 AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 59
TABLE 26 NORTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020-2027 (USD BILLION) 59
TABLE 27 NORTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 60
TABLE 28 NORTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 60
TABLE 29 NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 60
TABLE 30 NORTH AMERICA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 61
TABLE 31 NORTH AMERICA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 61
TABLE 32 NORTH AMERICA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 61
TABLE 33 NORTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 62
TABLE 34 US HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 62
TABLE 35 US HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 62
TABLE 36 US PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 63
TABLE 37 US FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 63
TABLE 38 US MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 63
TABLE 39 US DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 64
TABLE 40 US HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 64
TABLE 41 CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 64
TABLE 42 CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 65
TABLE 43 CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 65
TABLE 44 CANADA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 65
TABLE 45 CANADA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 66
TABLE 46 CANADA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 66
TABLE 47 CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 66
TABLE 48 SOUTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 67
TABLE 49 SOUTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 67
TABLE 50 SOUTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 67
TABLE 51 SOUTH AMERICA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 68
TABLE 52 SOUTH AMERICA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 68
TABLE 53 SOUTH AMERICA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 68
TABLE 54 SOUTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 69
TABLE 55 EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020-2027 (USD BILLION) 70
TABLE 56 EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 71
TABLE 57 EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 71
TABLE 58 EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 71
TABLE 59 EUROPE FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 72
TABLE 60 EUROPE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 72
TABLE 61 EUROPE DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 72
TABLE 62 EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 73
TABLE 63 WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020-2027 (USD BILLION) 73
TABLE 64 WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 74
TABLE 65 WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 74
TABLE 66 WESTERN EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 74
TABLE 67 WESTERN EUROPE FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 75
TABLE 68 WESTERN EUROPE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 75
TABLE 69 WESTERN EUROPE DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 75
TABLE 70 WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 76
TABLE 71 GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 76
TABLE 72 GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 76
TABLE 73 GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 77
TABLE 74 GERMANY FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 77
TABLE 75 GERMANY MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 77
TABLE 76 GERMANY DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 78
TABLE 77 GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 78
TABLE 78 FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 78
TABLE 79 FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 79
TABLE 80 FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 79
TABLE 81 FRANCE FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 79
TABLE 82 FRANCE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 80
TABLE 83 FRANCE DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 80
TABLE 84 FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 80
TABLE 85 UK HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 81
TABLE 86 UK HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 81
TABLE 87 UK PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 81
TABLE 88 UK FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 82
TABLE 89 UK MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 82
TABLE 90 UK DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 82
TABLE 91 UK HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 83
TABLE 92 ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 83
TABLE 93 ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 83
TABLE 94 ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 84
TABLE 95 ITALY FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 84
TABLE 96 ITALY MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 84
TABLE 97 ITALY DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 85
TABLE 98 ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 85
TABLE 99 SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 85
TABLE 100 SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 86
TABLE 101 SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 86
TABLE 102 SPAIN FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 86
TABLE 103 SPAIN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 87
TABLE 104 SPAIN DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 87
TABLE 105 SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 87
TABLE 106 REST OF WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 88
TABLE 107 REST OF WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 88
TABLE 108 REST OF WESTERN EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 88
TABLE 109 REST OF WESTERN EUROPE FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 89
TABLE 110 REST OF WESTERN EUROPE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 89
TABLE 111 REST OF WESTERN EUROPE DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 89
TABLE 112 REST OF WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 90
TABLE 113 EASTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 90
TABLE 114 EASTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 90
TABLE 115 EASTERN EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 91
TABLE 116 EASTERN EUROPE FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 91
TABLE 117 EASTERN EUROPE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 91
TABLE 118 EASTERN EUROPE DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 92
TABLE 119 EASTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 92
TABLE 120 ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020-2027 (USD BILLION) 93
TABLE 121 ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 94
TABLE 122 ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 94
TABLE 123 ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 94
TABLE 124 ASIA-PACIFIC FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 95
TABLE 125 ASIA-PACIFIC MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 95
TABLE 126 ASIA-PACIFIC DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 95
TABLE 127 ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 96
TABLE 128 JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 96
TABLE 129 JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 96
TABLE 130 JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 97
TABLE 131 JAPAN FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 97
TABLE 132 JAPAN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 97
TABLE 133 JAPAN DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 98
TABLE 134 JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 98
TABLE 135 CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 99
TABLE 136 CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 99
TABLE 137 CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 99
TABLE 138 CHINA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 100
TABLE 139 CHINA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 100
TABLE 140 CHINA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 100
TABLE 141 CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 101
TABLE 142 INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 101
TABLE 143 INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 101
TABLE 144 INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 102
TABLE 145 INDIA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 102
TABLE 146 INDIA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 102
TABLE 147 INDIA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 103
TABLE 148 INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 103
TABLE 149 AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 104
TABLE 150 AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 104
TABLE 151 AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 104
TABLE 152 AUSTRALIA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 105
TABLE 153 AUSTRALIA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 105
TABLE 154 AUSTRALIA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 105
TABLE 155 AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 106
TABLE 156 SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 106
TABLE 157 SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 106
TABLE 158 SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 107
TABLE 159 SOUTH KOREA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 107
TABLE 160 SOUTH KOREA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 107
TABLE 161 SOUTH KOREA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 108
TABLE 162 SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 108
TABLE 163 REST OF ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 108
TABLE 164 REST OF ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 109
TABLE 165 REST OF ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 109
TABLE 166 REST OF ASIA-PACIFIC FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 109
TABLE 167 REST OF ASIA-PACIFIC MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 110
TABLE 168 REST OF ASIA-PACIFIC DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 110
TABLE 169 REST OF ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 110
TABLE 170 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020-2027 (USD BILLION) 111
TABLE 171 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 112
TABLE 172 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 112
TABLE 173 MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 112
TABLE 174 MIDDLE EAST & AFRICA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 113
TABLE 175 MIDDLE EAST & AFRICA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 113
TABLE 176 MIDDLE EAST & AFRICA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 113
TABLE 177 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 114
TABLE 178 UAE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 114
TABLE 179 UAE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 114
TABLE 180 UAE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 115
TABLE 181 UAE FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 115
TABLE 182 UAE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 115
TABLE 183 UAE DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 116
TABLE 184 UAE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 116
TABLE 185 SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 117
TABLE 186 SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 117
TABLE 187 SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 117
TABLE 188 SAUDI ARABIA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 118
TABLE 189 SAUDI ARABIA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 118
TABLE 190 SAUDI ARABIA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 118
TABLE 191 SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 119
TABLE 192 OMAN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 119
TABLE 193 OMAN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 119
TABLE 194 OMAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 120
TABLE 195 OMAN FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 120
TABLE 196 OMAN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 120
TABLE 197 OMAN DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 121
TABLE 198 OMAN HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 121
TABLE 199 KUWAIT HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 122
TABLE 200 KUWAIT HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 122
TABLE 201 KUWAIT PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 122
TABLE 202 KUWAIT FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 123
TABLE 203 KUWAIT MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 123
TABLE 204 KUWAIT DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 123
TABLE 205 KUWAIT HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 124
TABLE 206 QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 124
TABLE 207 QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 124
TABLE 208 QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 125
TABLE 209 QATAR FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 125
TABLE 210 QATAR MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 125
TABLE 211 QATAR DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 126
TABLE 212 QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 126
TABLE 213 REST OF MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 126
TABLE 214 REST OF MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020-2027 (USD BILLION) 127
TABLE 215 REST OF MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 127
TABLE 216 REST OF MIDDLE EAST & AFRICA FDF MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 127
TABLE 217 REST OF MIDDLE EAST & AFRICA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020-2027 (USD BILLION) 128
TABLE 218 REST OF MIDDLE EAST & AFRICA DEVICE MANUFACTURING MARKET, BY TYPE, 2020-2027 (USD BILLION) 128
TABLE 219 REST OF MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020-2027 (USD BILLION) 128
15 List of Figures
FIGURE 1 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET: MARKET STRUCTURE 20
FIGURE 2 RESEARCH PROCESS OF MRFR 22
FIGURE 3 TOP-DOWN AND BOTTOM-UP APPROACH 25
FIGURE 4 MARKET DYNAMIC ANALYSIS OF THE GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET 27
FIGURE 5 DRIVERS IMPACT ANALYSIS: HEALTHCARE CONTRACT MANUFACTURING MARKET 29
FIGURE 6 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE CONTRACT MANUFACTURING MARKET 31
FIGURE 7 VALUE CHAIN: HEALTHCARE CONTRACT MANUFACTURING MARKET 34
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET 37
FIGURE 9 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY TYPE, 2020 & 2027 (USD BILLION) 42
FIGURE 10 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE BY TYPE, 2020 (%) 42
FIGURE 11 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2020 & 2027 (USD BILLION) 45
FIGURE 12 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE BY SERVICE TYPE, 2020 (%) 45
FIGURE 13 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY INDUSTRY, 2020 & 2027 (USD BILLION) 50
FIGURE 14 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE BY INDUSTRY, 2020 (%) 51
FIGURE 15 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020 & 2027 (USD BILLION) 54
FIGURE 16 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE BY REGION, 2020 (%) 55
FIGURE 17 AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020 (%) 56
FIGURE 18 NORTH AMERICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020 (%) 59
FIGURE 19 EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY REGION, 2020 (%) 70
FIGURE 20 WESTERN EUROPE HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020 (%) 73
FIGURE 21 ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020 (%) 93
FIGURE 22 MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2020 (%) 111
FIGURE 23 GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET: COMPANY SHARE ANALYSIS, 2020 (%) 130